Phytochemical Mining of Potential SARS-CoV-2 Main Protease Inhibitors from Blumea balsamifera (L.) DC.

Author:

Cayona Ruel,Creencia Evelyn

Abstract

Blumea balsamifera (L.) DC is a medicinal plant widely used against various ailments throughout Asian and African cultures. The reported efficacy of B. balsamifera and its phytochemicals against respiratory disorders suggests that it can be a potential therapeutic against the coronavirus disease 2019 (COVID-19), which is also a respiratory disease. This potential was demonstrated through an in silico assessment utilizing B. balsamifera phytochemicals and targeting the severe acute respiratory syndrome–coronavirus-2 main protease (SARS-CoV-2 Mpro), an enzyme that plays an important role in the infection process by SARS-CoV-2. The general strategy implemented was termed phytochemical mining in tandem with virtual screening (PM-VS). Data gathering of B. balsamifera phytochemicals reported in the literature was first conducted (PM stage) followed by VS through automated molecular docking of multiple ligands. The present study obtained the most comprehensive phytochemical record and organization of B. balsamifera phytochemicals (a total of 331). Surprisingly, 113 of the unique phytochemicals were promising SARS-CoV-2 Mpro inhibitors, of which 12 were re-discovered antiviral drugs from the plant. The promising inhibitors also reveal interesting in silico drug absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties. Further analysis of the promising phytochemicals and their interactions with SARS-CoV-2 Mpro hints at the phenylpropanoid moiety (Ph-C3-) as a potential pharmacophore of the target enzyme. This study illustrated the utility of PM-VS in the preliminary stages of drug discovery and development; however, further studies (e.g. exhaustive VS and definitive “ex silico” experiments) are needed to confirm the present finding.

Publisher

Science and Technology Information Institute

Subject

Multidisciplinary

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3